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Sister Mary Joseph Nodule as a First and Only Sign of
Extraovarian Carcinoma
A Case Report and Review of the Literature
Eva Kolwijck, MD; Roy F. Kruitwagen, MD, PhD; Leon F. Massuger, MD, PhD
● Sister Mary Joseph nodule is one of the less well-known
signs of intra-abdominal metastatic disease. The primary
tumor site is nearly always detected because of specific
morphologic and immunohistochemical features of the
umbilical tumor. We describe a case of a 74-year-old wom-
an with a Sister Mary Joseph nodule, which appeared most
likely to be metastatic from a primary serous papillary
ovarian carcinoma based on the histologic examination
and the immunohistochemical analysis. Despite an exten-
sive workup, no primary tumor could be detected and
therefore we ultimately diagnosed the tumor as an extra-
ovarian carcinoma with primary site at the umbilicus. After
a literature search we concluded that a primary adenocar-
cinoma of the umbilicus is extremely rare and to our
knowledge has never been described with both morpho-
logic and immunohistochemical features of a serous ovar-
ian carcinoma.
(Arch Pathol Lab Med. 2008;132:1943–1945)
Sister Mary Joseph nodule is a term introduced by Ham-ilton Bailey in 1960 for a malignant umbilical tumor.
It was named after Sister Mary Joseph, a nurse who was
the first person to observe umbilical nodules as one of the
less well-known signs of intra-abdominal metastatic dis-
ease. It can be the first symptom of an underlying cancer
or an indication of a recurrence in a patient with a pre-
vious intra-abdominal malignancy. Since then numerous
case reports have described such a tumor localization,
both in men and women, originating from different tumor
types, mainly adenocarcinomas.1,2 Whereas in men these
tumor nodules often are related to the gastrointestinal
tract, in women the main primary tumor is located in the
genital tract, especially the ovary.2 We present a case of a
patient in whom a Sister Mary Joseph nodule was identi-
fied, being the first and only sign of a (extraovarian) pap-
illary serous adenocarcinoma.
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REPORT OF A CASE
A 74 year-old woman was referred to a surgeon for excision
of a chronically infected umbilicus because conservative treat-
ment was unsuccessful. During this procedure, an umbilical her-
nia was also repaired. Histologic examination of the umbilical
mass identified the presence of a papillary serous adenocarci-
noma with multiple psammoma bodies and microcalcifications
(Figure, A and B). Immunohistochemistry was performed on for-
malin-fixed, paraffin-embedded tissue of the tumor using the im-
munoperoxidase method. The epithelial lining stained immuno-
positive for CA 125 at the apical surface of the cytoplasm (Figure,
C), for cytokeratin (CK) 7 in the cytoplasm (Figure, D), and for
estrogen receptor in the nucleus (Figure, F). It was 30% positive
for progesterone receptor in the nucleus and tested negative for
CK20 (Figure, E) and carcinoembryonic antigen. Based on this
morphology and immunohistochemical analysis the tumor ap-
peared most likely to be related to a primary ovarian carcinoma.
The patient was referred to our department at that point. At gy-
necologic examination, including transvaginal ultrasonography,
no abnormalities were found. A radiologic workup was initiated
(transvaginal ultrasonography, X-mammography, computed to-
mography of thorax and abdomen), which again showed no ab-
normalities. Serum CA 125, CA 15.3, and carcinoembryonic an-
tigen levels were normal. Endometrial histology, obtained by di-
latation and curettage, showed an atrophic endometrium. At lap-
aroscopy no abnormalities were found and a bilateral
salpingo-oophorectomy was performed. Despite ultrasectioning,
histologic examination revealed no primary tumor localization.
Finally it was decided to perform a complete staging laparot-
omy, composed of a hysterectomy, numerous peritoneal biopsies,
a pelvic retroperitoneal lymph node sampling, and an infracolic
omentectomy. Again, histologic examination revealed no primary
tumor localizations and therefore no adjuvant chemotherapy was
started. Seven months after excision of the umbilical tumor, the
patient showed no evidence of disease.
COMMENT
So far, a Sister Mary Joseph nodule has been interpreted
as the expression of metastatic disease of different intra-
abdominal tumor types. Despite the fact that these tumor
nodules sometimes can be the first symptom, during fur-
ther workup the primary tumor site nearly always is iden-
tified, and in women often appears to be the ovary. This
identification is relatively easy because most umbilical ad-
enocarcinomas have specific histologic and immunohis-
tochemical features that enable a fairly confident predic-
tion of the probable site of the primary tumor.2
Most authors support the idea that these metastatic le-
sions in the umbilicus are the result of lymphatic and/or
hematogenic spread, or by extension per continuitatem
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Stained tissue sections of the adenocarcinoma of unknown primary origin. A and B, Hematoxylin-eosin–stained section shows a papillary pattern
of malignant cells and psammoma calcifications (original magnifications100 [A] and200 [B]). Immunohistochemistry using immunoperoxidase
method on the same tumor shows a positive staining for CA 125 (C), cytokeratin 7 (D), and estrogen receptor (F) and a negative staining for
cytokeratin 20 (E) (original magnifications 100).
from the peritoneal surface.2,3 In addition, iatrogenic me-
tastases after laparoscopy at the umbilical port site have
been reported. Possible mechanisms for this phenomenon
include direct or indirect seeding of tumor cells due to
excessive manipulation, leakage of insufflation gas
through the port site (chimney effect), replacement of tro-
cars, unprotected retraction of tumor tissue, and the CO2
pneumoperitoneum that causes diffuse damage to the en-
tire mesothelial layer.4
Primary malignant umbilical tumors are rare and most-
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ly comprise melanomas and squamous and basal cell car-
cinomas. The diagnosis of primary umbilical adenocarci-
noma can be suspected when an alternative primary can-
cer has been searched for but not found by complete ex-
amination.2 In his 1966 review of the literature, Barrow3
found 29 cases of primary umbilical adenocarcinomas of
which 24 were reported by Cullen in 1916 and were col-
lected around the turn of the century or before. Steck and
Helwig1 declared that the reports of Cullen offered little
proof that the umbilical lesion was primary or even cancer.
Moreover, in their series of 48 malignant umbilical tumors
they only found 1 possible primary adenocarcinoma. For
this reason they concluded that proof of a diagnosis of
primary adenocarcinoma in the umbilicus is extremely
rare and very difficult to establish.
After a literature search we could only find 1 case report
of a primary umbilical adenocarcinoma that was thought
to be metastatic from an ovarian primary neoplasm.5 His-
tologic examination revealed a well-differentiated papil-
lary adenocarcinoma with psammoma bodies. However,
no immunohistochemical analysis was performed, which
means that the type of histology described may be related
to other intra-abdominal malignancies as well. After this
case was reported in 1975, in which no primary (ovarian)
tumor could be detected, no other extraovarian umbilical
adenocarcinomas were reported until now.
It is suggested that primary umbilical adenocarcinoma
arises from an embryologic remnant connected to the um-
bilicus, such as the omphalomesenteric (OM) duct or the
urachus.1,5 The OM duct is a tubular structure that joins
the gut of the early embryo to the yolk sac. Remnants of
the duct may persist anywhere along its course and com-
monly contain gastrointestinal mucosa (primarily consist-
ing of columnar and mucus-secreting goblet cells) and
smooth muscle. Steck and Helwig6 studied 40 patients
with cutaneous remnants of the OM duct but failed to
detect any neoplasm. The only OM neoplasms described
so far are of Meckel diverticulum, a remnant of the most
proximal part of the OM duct. Rarely, malignant tumors
arise in this site and almost always comprise carcinoids.
The few cases of adenocarcinomas of Meckel diverticulum
reported were of gastrointestinal type.7
The urachus runs downward in the extraperitoneal
space from the umbilicus to the apex of the bladder. Pri-
mary urachal adenocarcinomas account for less than 1%
of all urinary bladder cancers and theoretically might oc-
cur at any point up to the umbilicus. Malignant urachal
tumors mostly are well-differentiated mucinous adenocar-
cinomas and are occasionally signet-ring cell carcinomas.8
Three cases of a primary urachal adenocarcinoma with
ovarian metastases that mimicked primary ovarian mucin-
ous adenocarcinoma have been described.8–10 Arguments
for these ovarian tumors being metastatic from the urachal
tumor rather than primary ovarian carcinoma were the
occurrence of the ovarian tumor localizations after occur-
rence of the urachal tumor and a characteristic morphol-
ogy (mucinous adenocarcinoma) and immunohistochemi-
cal profile (CK20 receptor positive and CK7 receptor neg-
ative) being more consistent with metastatic rather than
primary ovarian carcinoma.8
In our patient, the histology of the tumor nodule was
in accordance with a papillary serous adenocarcinoma of
the ovary, both morphologically (existence of psammoma
bodies) as well as immunohistochemically (CK7, estrogen
receptor, progesterone receptor, and CA 125 receptor pos-
itive). Despite an extensive workup to find the primary
tumor localization, including a complete staging laparot-
omy as in primary (extra)ovarian cancer, no primary tu-
mor was found. Therefore, a primary site in the umbilicus
was accepted by default. However, it is questionable if the
tumor arose within an ectopic remnant of the umbilicus
because of the difference in histology and morphology
compared with common malignancies of the OM duct and
urachus. In addition, although unlikely, we could not com-
pletely rule out the existence of an occult primary serous
carcinoma because the follow-up time was only 7 months.
In conclusion, to our knowledge, this report describes a
unique case of a malignant umbilical tumor nodule with
ovarian carcinoma–like appearance as the only sign of a
malignancy supporting the idea of a primary extraovarian
tumor site at the umbilicus.
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